Historical record - last NADAC effective date: 7/6/2016

Product Information

ACTOS 15 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.1190 per EA under NDC 64764015106. Its NADAC has been published 122 times since Nov 28, 2013.

FDA first approved this application on Jul 15, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACTOS 15 MG TABLET

pioglitazone
$12.1190per EA
High Outlier

Strength

15 mg/1

NDC

64764015106

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

7/6/2016

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021073

FDA Approved

7/15/1999

TE Code

AB

On Market Since

7/15/1999

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for ACTOS 15 MG TABLET has been published 122 times since Nov 28, 2013, and over the history we have for it it has risen 63.0%. The table below summarizes its recorded NADAC range and movement.

Current price$12.1190 per EA
All-time high$12.1190 (Sep 14, 2016)
All-time low$7.4371 (Nov 28, 2013)
Median price$11.0274
Average price$10.2559
Largest weekly change+12.8% (Aug 27, 2014)
Weeks tracked122
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+63.0%

Last surveyed Sep 14, 2016 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACTOS 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ACTOS 15 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.1190 per EA (NDC 64764015106), effective Sep 14, 2016.

How has the price of ACTOS 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for ACTOS 15 MG TABLET has risen 63.0%. It has been tracked across 122 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACTOS 15 MG TABLET?

Since Nov 28, 2013, the NADAC for ACTOS 15 MG TABLET has ranged from a low of $7.4371 (Nov 28, 2013) to a high of $12.1190 (Sep 14, 2016), with a median of $11.0274 per EA.

Are there cheaper alternatives to ACTOS 15 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACTOS 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ACTOS 15 MG TABLET?

ACTOS 15 MG TABLET (NDC 64764015106) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.